The Scottish Motor Neuron Disease Register (SMNDR) is a prospective, collaborative, population based study of motor neuron disease (MND) in Scotland. The register started in January 1989 with the aim of studying the clinical and epidemiological features of MND by prospectively identifying incident patients. It is based on a system of registration by recruitment from multiple sources, followed by the collection of complete clinical data and follow up, mainly through general practioners. In this report the register's methodology and the demography and incidence data for the first year of study are presented. One hundred and fourteen newly diagnosed patients were identified in 1989 giving a crude incidence for Scotland of 2*241100 000/year. Standardised incidence ratios showed a non-significant trend towards lower rates in north eastern regions and island areas.
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The motor neuron diseases (MND) occur at any age but most of the childhood forms (spinal muscular atrophies) are familial, and a result of a mutation on the long arm of chromosome 5.' In contrast, although some forms of adult onset MND have a genetic basis,2 with linkage to chromosome 21,3 the vast majority are sporadic. Numerous diverse theories of aetiology have been summarised in recent reviews`6 but there is still no universally accepted cause or effective treatment. Amyotrophic lateral sclerosis (ALS), progressive bulbar palsy (PBP), and progressive muscular atrophy (PMA), the principal subtypes, are almost certainly clinical variants of a single disease6 with the common underlying pathological finding of anterior horn cell degeneration. Primary lateral sclerosis (PLS), a much debated but probably true entity, may be a separate disorder. 7 The incidence of MND may not be as static or as uniform as was once believed. 8 If the distribution of the disease in time and place is changing then this might provide clues to its cause. There is evidence for an environmental influence in the Western Pacific forms of MND which has largely been derived from epidemiological studies,9 1O informed of the study's progress by a monthly newsletter, were encouraged to send copies of follow up correspondence from hospital clinics. A paper file is maintained for each patient. A dBase IV computer system was used to construct a database for compiling features of key interest and permitting organised retrieval of data.
The 1989 population estimate for Scotland and its regions'3 (derived from the last population census in 1981) was used for the calculation of rates and standardised incidence ratios. Age specific incidence was calculated using age at diagnosis, usually in relation to the first admission to hospital for investigations. The significance of differences between the means for ages according to sex was examined using the Students t test. Age adjusted standardised incidence ratios (of observed to expected cases) were calculated for each of the nine regions and three island areas using the indirect method. ' mortality records; and one from pathology records. Ninety two patients (81%) had been seen at some time by a neurologist and 95 (83%) had had an EMG. Sixty two patients (54%) were men [mean (SD) age at diagnosis 62-5 (12 4) range 27-84 years], 52 (46%) were women [mean (SD) age at diagnosis 68-0 (12-1) range 31-91 years], giving a male to female ratio of 1-2: 1. The difference in ages was significant (5-5 years, 95% CI 0 9-10 1).
The classification of the patients' clinical status, is given in table 3. Patients with PBP and PMA only at onset were in the minority and most individuals presenting with PBP evolved into the PBP/ALS group. Six patients (5%) had a family history of MND but none was related to each other.
The crude incidence for Scotland was 2-24/100 000/year (95% CI 1-83 to 2-65). Age and sex specific incidence rates (presented in table 4) continued to rise to a peak between 75-84 years for women and 65-74 years for men (fig 1) . The number of patients older than 85 years was very small making interpretation of rates in the very elderly difficult. The age adjusted standardised incidence ratios for individual regions showed some variation (fig 2) . Ninety five per cent confidence limits overlapped with unity, however, indicating none was significantly different from the expected at the p < 0 05 level, although lower standardised ratios were observed in the north east and island areas.
Discussion
The epidemiological method may provide important clues to the causes of MND by demonstrating temporal and geographical trends in distribution. Difficulties arise in delineating the optimum size for such a study: under-reporting and error in diagnosis will bias mortality studies based on very large populations, whereas random variation will lead to imprecise estimates if a sample used is too small. In this study, which will continue to accrue registrations, the size has not compromised diagnostic accuracy because data can be sought prospectively. The population base is such that a useful number of patients can be registered within a few years and thereby offers the opportunity to provide a valuable long term study of MND in Scotland. In addition, the methods of the SMNDR are unique with Western Isles 0-0 (0O0-4-9) Table 4 Age-sex specific incidence rates for MND in Scotland (1989) 22 Forty four patients were included in that population based study between 1925-84 giving a crude incidence of 2-0/100 000/year (95% CI 1-4 to 2 7). The incidence of MND has been examined in a number of other countries but in only two, both from Scandinavia,23 24 
